Meyka Pro banner
Sight Sciences, Inc.

Sight Sciences, Inc. (SGHT) Stock Overview

Explore Sight Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SGHT●NASDAQ
HealthcareMedical - Devices
$11.01
$0.93(9.23%)
U.S. Market opens in 15h 51m

Sight Sciences, Inc. (SGHT)

Meyka AI Score

Z

Key Financials

Market Cap606M
P/E Ratio-19.16
EPS (TTM)$-0.56
ROE-0.52%
Fundamental Analysis

AI Price Forecasts

1 Month$12.17
3 Months$10.54
1 Year Target$8.32

SGHT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Sight Sciences, Inc. (NASDAQ: SGHT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sight Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SGHT on the NASDAQ shows an RSI of 75.66, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $8.32 for the NASDAQ listing.

Key metrics behind Sight Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -19.16 and a market capitalization of 606M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SGHT on the NASDAQ.

Price Performance (NASDAQ: SGHT)

1-Day Change
9.23%
5-Day Change
19.41%
1-Month Change
23.85%
3-Month Change
47.39%
6-Month Change
104.65%
Year-to-Date (YTD) Change
38.84%
1-Year Change
68.87%
3-Year Change
527.35%
5-Year Change
-54.30%
All-Time (Max) Change
-67.13%

Contact Information

877 266 1144
4040 Campbell Avenue, Menlo Park, CA, 94025

Company Facts

1,860 Employees
IPO DateJul 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions